Successful use of intravenous and intralesional rituximab in paraneoplastic pemphigus with Castleman's disease

Int J Dermatol. 2021 Sep;60(9):e352-e354. doi: 10.1111/ijd.15528. Epub 2021 Mar 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Castleman Disease* / complications
  • Castleman Disease* / drug therapy
  • Humans
  • Paraneoplastic Syndromes* / drug therapy
  • Paraneoplastic Syndromes* / etiology
  • Pemphigus* / complications
  • Pemphigus* / drug therapy
  • Rituximab

Substances

  • Rituximab